[go: up one dir, main page]

WO2003013614A1 - Preparations, medicaments et quasi-medicaments destines a la voie orale contenant du collagene - Google Patents

Preparations, medicaments et quasi-medicaments destines a la voie orale contenant du collagene Download PDF

Info

Publication number
WO2003013614A1
WO2003013614A1 PCT/JP2002/007929 JP0207929W WO03013614A1 WO 2003013614 A1 WO2003013614 A1 WO 2003013614A1 JP 0207929 W JP0207929 W JP 0207929W WO 03013614 A1 WO03013614 A1 WO 03013614A1
Authority
WO
WIPO (PCT)
Prior art keywords
drugs
collagen
oral preparations
quasi
containing oral
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/JP2002/007929
Other languages
English (en)
Japanese (ja)
Inventor
Kikuji Yamashita
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Techno Network Shikoku Co Ltd
Original Assignee
Techno Network Shikoku Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Techno Network Shikoku Co Ltd filed Critical Techno Network Shikoku Co Ltd
Publication of WO2003013614A1 publication Critical patent/WO2003013614A1/fr
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4196—1,2,4-Triazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/255—Esters, e.g. nitroglycerine, selenocyanates of sulfoxy acids or sulfur analogues thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/429—Thiazoles condensed with heterocyclic ring systems
    • A61K31/43—Compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula, e.g. penicillins, penems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/542—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/545—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine
    • A61K31/546—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine containing further heterocyclic rings, e.g. cephalothin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/42—Proteins; Polypeptides; Degradation products thereof; Derivatives thereof, e.g. albumin, gelatin or zein
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
    • A61K8/65—Collagen; Gelatin; Keratin; Derivatives or degradation products thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q11/00—Preparations for care of the teeth, of the oral cavity or of dentures; Dentifrices, e.g. toothpastes; Mouth rinses

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Birds (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Dermatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Inorganic Chemistry (AREA)
  • Emergency Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Cosmetics (AREA)

Abstract

L'invention concerne des préparations, des médicaments et des quasi-médicaments destinés à la voie orale qui contiennent de l'atélocollagène, du collagène fibreux, du collagène réticulé, du collagène réticulé calcifié, du collagène traité de façon enzymatique possédant un poids moléculaire de 300 000 ou plus, des gélatines fabriquées à partir des collagènes respectifs ou de la gélatine hydrolysée ou digérée de façon enzymatique comme absorbant pour le principe actif.
PCT/JP2002/007929 2001-08-06 2002-08-02 Preparations, medicaments et quasi-medicaments destines a la voie orale contenant du collagene Ceased WO2003013614A1 (fr)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
JP2001-237954 2001-08-06
JP2001237954 2001-08-06
JP2002-134223 2002-05-09
JP2002134223A JP2003119156A (ja) 2001-08-06 2002-05-09 コラーゲンを含有する口腔用剤、医薬品および医薬部外品

Publications (1)

Publication Number Publication Date
WO2003013614A1 true WO2003013614A1 (fr) 2003-02-20

Family

ID=26620019

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/JP2002/007929 Ceased WO2003013614A1 (fr) 2001-08-06 2002-08-02 Preparations, medicaments et quasi-medicaments destines a la voie orale contenant du collagene

Country Status (2)

Country Link
JP (1) JP2003119156A (fr)
WO (1) WO2003013614A1 (fr)

Citations (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3443261A (en) * 1967-09-01 1969-05-13 Fmc Corp Prosthetic structures from microcrystalline collagen
GB1271763A (en) * 1969-05-12 1972-04-26 Fmc Corp New or improved structures for example, prstuetic structures, and a method of preparing them
JPS579711A (en) * 1980-06-20 1982-01-19 Japan Atom Energy Res Inst Preparation of prolonged release type complex
EP0230647A2 (fr) * 1985-12-27 1987-08-05 Sumitomo Pharmaceuticals Company, Limited Procédé pour la préparation d'une formulation à action retardée
EP0243002A2 (fr) * 1986-03-25 1987-10-28 Rohto Pharmaceutical Co., Ltd. Composition pharmaceutique pour le traitement de maladies péridontales
EP0328389A2 (fr) * 1988-02-11 1989-08-16 Matrix Pharmaceutical Inc. Compostions pour le traitement des tumeurs intracrâniennes
WO1993012736A1 (fr) * 1991-12-30 1993-07-08 Norian Corporation Collagene mineralise
JPH0733643A (ja) * 1993-07-16 1995-02-03 G C:Kk 歯周投与用基剤及び歯周投与用製剤
JPH11151438A (ja) * 1997-11-20 1999-06-08 National Institute Of Sericultual And Entomological Science 生体高分子からなる吸着体／徐放体、その製造方法、および吸着方法

Patent Citations (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3443261A (en) * 1967-09-01 1969-05-13 Fmc Corp Prosthetic structures from microcrystalline collagen
GB1271763A (en) * 1969-05-12 1972-04-26 Fmc Corp New or improved structures for example, prstuetic structures, and a method of preparing them
JPS579711A (en) * 1980-06-20 1982-01-19 Japan Atom Energy Res Inst Preparation of prolonged release type complex
EP0230647A2 (fr) * 1985-12-27 1987-08-05 Sumitomo Pharmaceuticals Company, Limited Procédé pour la préparation d'une formulation à action retardée
EP0243002A2 (fr) * 1986-03-25 1987-10-28 Rohto Pharmaceutical Co., Ltd. Composition pharmaceutique pour le traitement de maladies péridontales
EP0328389A2 (fr) * 1988-02-11 1989-08-16 Matrix Pharmaceutical Inc. Compostions pour le traitement des tumeurs intracrâniennes
WO1993012736A1 (fr) * 1991-12-30 1993-07-08 Norian Corporation Collagene mineralise
JPH0733643A (ja) * 1993-07-16 1995-02-03 G C:Kk 歯周投与用基剤及び歯周投与用製剤
JPH11151438A (ja) * 1997-11-20 1999-06-08 National Institute Of Sericultual And Entomological Science 生体高分子からなる吸着体／徐放体、その製造方法、および吸着方法

Also Published As

Publication number Publication date
JP2003119156A (ja) 2003-04-23

Similar Documents

Publication Publication Date Title
WO2001034647A3 (fr) Collagenes et gelatines animaux
WO2000030672A8 (fr) Biomatieres a base de collagene et procedes de preparation et d'utilisation
IT1275434B (it) Composizioni farmaceutiche e/o dietetiche ad attivita' antiossidante
WO2001078680A3 (fr) Compositions pharmaceutiques
WO2001034646A3 (fr) Gelatines de recombinaison
KR970702705A (ko) 수술도구 운반, 조종 및 추출을 위한 의료형 선형 액추에이터(medical linear actuator for surgical delivery. manuipulation. and extraction)
FI964323L (fi) Kirurginen implantaatti, väline tai sen osa
AU6069098A (en) Partially tied surgical knot
BR9710979B1 (pt) composiÇço preparada a partir de um produto de carbano modificado.
EP2364997A3 (fr) Variantes de polypeptide et fonction effectrice altérée
DE50008336D1 (de) Mehrschichttablette zur verabreichung einer fixen kombination von tramadol und diclofenac
FR2805465B1 (fr) Nouvelles compositions pharmaceutique ou dietetiques a base de champignons
CA2368574A1 (fr) Compositions destinees a la prevention et au traitement de l'allergie de type i
FI971533A7 (fi) Lyofilisoituja farmaseuttisia valmisteita, jotka kykenevät muodostamaa n vesipitoisen lääkekoostumuksen, jolla on palautuvan, lämpökovettuvan geelittymisen ominaisuus
DE60020738D1 (de) Teilchenförmige vitaminzubereitung
WO2000076528A3 (fr) Preparation pharmaceutique
AU5305000A (en) Novel genes encoding proteins having diagnostic, preventive, therapeutic, and other uses
WO2001078682A3 (fr) Compositions pharmaceutiques a liberation prolongee
DE69616074D1 (de) Ara-c derivate
NO963526L (no) N-metyl-N-£(1S)-1-fenyl-2-((3S)-3-hydroksypyrrolidin-1-yl)-etyl|-2,2-difenylacetamid
AU5992198A (en) Novel arylpiperazine derived from piperidine as antidepressant medicines
GEP20063820B (en) Orodispersible pharmaceutical composition comprising ivabradine
GEP20063821B (en) Orodispersible pharmaceutical composition comprising perindopril
ES2139332T3 (es) Procedimiento para la preparacion del trihidrato del (2r,3s)-3-benzoilamino-2-hidroxi-3-fenilpropionato de 4,10-diacetoxi-2alfa-benzoiloxi-5beta,20-epoxi-1,7beta-dihidroxi-9-oxo-tax-11-en-13alfa-ilo.
WO2003013614A1 (fr) Preparations, medicaments et quasi-medicaments destines a la voie orale contenant du collagene

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A1

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BY BZ CA CH CN CO CR CU CZ DE DM DZ EC EE ES FI GB GD GE GH HR HU ID IL IN IS KE KG KP KR KZ LK LR LS LT LU LV MA MD MG MK MW MX MZ NO NZ OM PH PL PT RO SD SE SG SI SK SL TJ TM TN TR TT UA UG US UZ VN YU ZA ZM

Kind code of ref document: A1

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ OM PH PL PT RO RU SD SE SG SI SK SL TJ TM TN TR TT TZ UA UG US UZ VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A1

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR IE IT LU MC NL PT SE SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

Kind code of ref document: A1

Designated state(s): GH GM KE LS MW MZ SD SL SZ UG ZM ZW AM AZ BY KG KZ RU TJ TM AT BE BG CH CY CZ DK EE ES FI FR GB GR IE IT LU MC PT SE SK TR BF BJ CF CG CI GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

122 Ep: pct application non-entry in european phase